ConductScience.org, home

Paper16614977

Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.

Rost D and 3 others. Dig Dis Sci, 2006. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis. Papers, record 16614977. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16614977

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.
PubMed
Journal
Dig Dis Sci
PubMed
Year
2006
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.17
iCite
Revised in PubMed
2021-10-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rost DD
2Rudolph GG
3Kloeters-Plachky PP
4Stiehl AA

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cholangitis, SclerosingMajor topic
ColitisMajor topic
Colonic PouchesMajor topic
Ursodeoxycholic AcidMajor topic
Adult
Bile Acids and Salts
Case-Control Studies
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Male
Maximum Tolerated Dose
Probability
Reference Values
Risk Assessment
Treatment Outcome

Source PubMed

Download CSV of topics

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18259039Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats.Liver1993https://conductscience.org/library/papers/8259039PubMed
21959845Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.Hepatology1991https://conductscience.org/library/papers/1959845PubMed
31537519Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage.Gastroenterology1992https://conductscience.org/library/papers/1537519PubMed
49287980Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis.Gastroenterology1997https://conductscience.org/library/papers/9287980PubMed
57435569Metabolism in man of 7-ketolithocholic acid: precursor of cheno- and ursodeoxycholic acids.Am J Physiol1980https://conductscience.org/library/papers/7435569PubMed
611830325Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment.J Hepatol2002https://conductscience.org/library/papers/11830325PubMed
710510466Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation.Cell Death Differ1999https://conductscience.org/library/papers/10510466PubMed
89918905Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.Hepatology1999https://conductscience.org/library/papers/9918905PubMed
99537871Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes.J Hepatol1998https://conductscience.org/library/papers/9537871PubMed
102777202Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.Hepatology1989https://conductscience.org/library/papers/2777202PubMed
112295398Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.Gastroenterology1990https://conductscience.org/library/papers/2295398PubMed
12864325Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry.J Lipid Res1977https://conductscience.org/library/papers/864325PubMed
131983822Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.Gastroenterology1991https://conductscience.org/library/papers/1983822PubMed
141505913Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.Hepatology1992https://conductscience.org/library/papers/1505913PubMed
1510347103Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.Hepatology1999https://conductscience.org/library/papers/10347103PubMed
162401454Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes.Hepatology1990https://conductscience.org/library/papers/2401454PubMed
178174892Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts.Gastroenterology1994https://conductscience.org/library/papers/8174892PubMed
1815349909Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis.Hepatology2004https://conductscience.org/library/papers/15349909PubMed
1910219843Influence of cholestasis on absorption of ursodeoxycholic acid.Dig Dis Sci1999https://conductscience.org/library/papers/10219843PubMed
202391610Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.J Pediatr1990https://conductscience.org/library/papers/2391610PubMed

See all 33 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
20564380Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.Hepatology2010https://conductscience.org/library/papers/20564380PubMed
17391626Treatment of primary sclerosing cholangitis.Curr Treat Options Gastroenterol2007https://conductscience.org/library/papers/17391626PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16614977

GET https://conductscience.org/api/papers/v1/16614977/references?page=2